Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry

Journal of Biomedicine and Biotechnology

Volumn 2008, Issue 1, 2008, Pages

  Chouchane, Lotfi ^g   Kabbage, Maria ^a   Chahed, Karim ^a,b   Hamrita, Bechr ^a   Guillier, Christelle Lemaitre ^c   Trimeche, Mounir ^d   Remadi, Sami ^e   Hoebeke, Johan ^f  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c CNRS   (France)

^d FARHAT HACHED HOSPITAL   (Tunisia)

^e Laboratoire Cytopath   (Tunisia)

^f INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^g WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA B CRYSTALLIN; CHAPERONE; COFILIN 1; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3C; CYCLOPHILIN A; CYTOSKELETON PROTEIN; DEOXYHEMOGLOBIN; ENOLASE; GLYCOLYTIC ENZYME; HEAT SHOCK PROTEIN 27; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHOGLYCERATE KINASE; RIBONUCLEOPROTEIN; RIBONUCLEOPROTEINS A2 B1; SUPEROXIDE DISMUTASE; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; ELECTROPHORESIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFILTRATING DUCTAL CARCINOMA; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN FUNCTION; BREAST TUMOR; CHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; MUTATION; PAGET NIPPLE DISEASE; PH;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; ELECTROPHORESIS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MASS SPECTROMETRY; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 42949169998     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2008/564127     Document Type: Article

References (42)

1. Jemal A., Thomas A., Murray T., Thun M., Cancer statistics CA: A Cancer Journal for Clinicians 2002 52 1 23 47
2. Parkin D. M., Ferlay J., Hamdi Cherif M., Cancer in Africa: Epidemiology and Prevention 2003 Lyon, France IARC Press IARC Scientific Publications
3. Hondermarck H., Breast cancer: when proteomics challenges biological complexity Molecular & Cellular Proteomics 2003 2 281 291
4. He Q.-Y.
5. Wulfkuhle J. D., Sgroi D. C., Krutzsch H., Proteomics of human breast ductal carcinoma in situ Cancer Research 2002 62 22 6740 6749
6. Görg A., Weiss W., Dunn M. J., Current two-dimensional electrophoresis technology for proteomics Proteomics 2004 4 12 3665 3685
7. Herbert B. R., Sanchez C., Bin L., Wilkins M. R., Williams K. I., Appel R. D., Hochstrasser D. F., Two dimensional electrophoresis: the state of the art and future directions Proteome Research: New Frontiers in Functional Genomics 1997 New York, NY, USA Springer 13 33
8. O'Farrell P. Z., Goodman H. M., O'Farrell P. H., High resolution two-dimensional electrophoresis of basic as well as acidic proteins Cell 1977 12 4 1133 1142
9. Chahed K., Kabbage M., Ehret-Sabatier L., Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses International Journal of Oncology 2005 27 5 1425 1431
10. Sobin L. H., Fleming I. D., TNM classification of malignant tumors,fifth edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer Cancer 1997 80 9 1803 1804
11. Elston C. W., Ellis I. O., Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 1991 19 5 403 410
12. Ramagli L. S., Rodriguez L. U., Quantification of microgram amounts of proteins in two-dimensional polyacrylamide gel electrophoresis sample buffer Electrophoresis 1985 6 11 559 563
13. Neuhoff V., Stamm R., Eibl H., Clear background and highly sensitive protein staining with Coomassie Blue dyes in polyacrylamide gels: a systematic analysis Electrophoresis 1985 6 9 427 448
14. Schauenstein E., Rabl H., Steinschifter W., Hirschmann C., Estelberger W., Schauenstein K., Selective decrease of serum immunoglobulin G1 as a marker of malignant transformation in colorectal tissue Cancer 1997 79 8 1482 1486
15. Chen Y.
16. Schauenstein E., Lahousen M., Weblacher M., Steinschifter W., Estelberger W., Schauenstein K., Selective decrease in serum immunoglobulin G1: a tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiency Cancer 1996 78 3 511 516
17. Anderhuber W., Steinschifter W., Gotschuli A., Schauenstein E., Schauenstein K., Quantitative changes in the immunoglobulin G subclass system - a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck Laryngorhinootologie 1998 77 10 564 568
18. Kronberger L., Steinschifter W., Weblacher M., Selective decrease of serum immunoglobulin G1 as marker for early stages of invasive breast cancer Breast Cancer Research and Treatment 2000 64 2 193 199
19. Felsner P., Steinschifter W., Fischer M., The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignancies Cancer 2000 88 2 461 467
20. Kawano Y., Noma T., Yata J., Regulation of human IgG subclass production by cytokines: IFN- γ and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2 Journal of Immunology 1994 153 11 4948 4958
21. Jurianz K., Ziegler S., Donin N., Reiter Y., Fishelson Z., Kirschfink M., K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement International Journal of Cancer 2001 93 6 848 854
22. Caragine T. A., Okada N., Frey A. B., Tomlinson S., A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer Cancer Research 2002 62 4 1110 1115
23. Lorenz K., Lohse M. J., Quitterer U.
24. Yeung K., Janosch P., McFerran B., Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the Raf kinase inhibitor protein Molecular and Cellular Biology 2000 20 9 3079 3085
25. Emoto K., Toyama-Sorimachi N., Karasuyama H., Inoue K., Umeda M.
26. Wang X., Li N., Liu B., A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor α -induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization Journal of Biological Chemistry 2004 279 44 45855 45864
27. Wang X., Li N., Li H., Silencing of human phosphatidylethanolamine- binding protein 4 sensitizes breast cancer cells to tumor necrosis factor- α -induced apoptosis and cell growth arrest Clinical Cancer Research 2005 11 20 7545 7553
28. Sherry B., Yarlett N., Strupp A., Cerami A., Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages Proceedings of the National Academy of Sciences of the United States of America 1992 89 8 3511 3515
29. Melle C., Osterloh D., Ernst G., Schimmel B., Bleul A., von Eggeling F., Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry International Journal of Molecular Medicine 2005 16 1 11 17
30. Li M.
31. Wheeler M. D.
32. Chen J., He Q.-Y.
33. Trabold O., Wagner S., Wicke C., Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing Wound Repair and Regeneration 2003 11 6 504 509
34. Wang W.
35. Yap C. T., Simpson T. I., Pratt T., Price D. J., Maciver S. K.
36. Dang D., Bamburg J. R., Ramos D. M.
37. Kiang J. G., Tsokos G. C., Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology Pharmacology & Therapeutics 1998 80 2 183 201
38. Korneeva I., Bongiovanni A. M., Girotra M., Caputo T. A., Witkin S. S.
39. Sarto C.
40. Parcellier A., Schmitt E., Brunet M., Hammann A., Solary E., Garrido C.
41. Kamradt M. C., Chen F., Cryns V. L.
42. Kamradt M. C., Lu M., Werner M. E., The small heat shock protein α B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3 Journal of Biological Chemistry 2005 280 12 11059 11066